Our top pick for
ReneSola Ltd is a solar business based in the US. ReneSola shares (SOL) are listed on the NYSE and all prices are listed in US Dollars. ReneSola employs 147 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$7.85|
|52-week range||$2.97 - $35.77|
|50-day moving average||$6.82|
|200-day moving average||$7.96|
|Wall St. target price||$11.80|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.24|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||8.28%|
|1 month (2021-09-22)||14.93%|
|3 months (2021-07-23)||12.46%|
|6 months (2021-04-23)||-22.35%|
|1 year (2020-10-23)||119.89%|
|2 years (2019-10-23)||401.25%|
|3 years (2018-10-23)||308.85%|
|5 years (2016-10-21)||697.76%|
Valuing ReneSola stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ReneSola's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ReneSola's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, ReneSola shares trade at around 29x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
ReneSola's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7537. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into ReneSola's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
ReneSola's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.5 million.
The EBITDA is a measure of a ReneSola's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$67.5 million|
|Gross profit TTM||$16.7 million|
|Return on assets TTM||-0.07%|
|Return on equity TTM||3.88%|
|Market capitalisation||$486.8 million|
TTM: trailing 12 months
There are currently 1.9 million ReneSola shares held short by investors – that's known as ReneSola's "short interest". This figure is 61.3% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting ReneSola shares can be evaluated.
ReneSola's "short interest ratio" (SIR) is the quantity of ReneSola shares currently shorted divided by the average quantity of ReneSola shares traded daily (recently around 1.3 million). ReneSola's SIR currently stands at 1.44. In other words for every 100,000 ReneSola shares traded daily on the market, roughly 1440 shares are currently held short.
However ReneSola's short interest can also be evaluated against the total number of ReneSola shares, or, against the total number of tradable ReneSola shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ReneSola's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 ReneSola shares in existence, roughly 30 shares are currently held short) or 0.0503% of the tradable shares (for every 100,000 tradable ReneSola shares, roughly 50 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ReneSola.
Find out more about how you can short ReneSola stock.
We're not expecting ReneSola to pay a dividend over the next 12 months.
ReneSola's shares were split on a 1:5 basis on 9 February 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ReneSola shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for ReneSola shares which in turn could have impacted ReneSola's share price.
Over the last 12 months, ReneSola's shares have ranged in value from as little as $2.97 up to $35.7748. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while ReneSola's is 2.2392. This would suggest that ReneSola's shares are significantly more volatile than the average for this exchange and represent a higher risk.
ReneSola Ltd, through its subsidiaries, develops, builds, operates, and sells solar power projects in the United States and Europe. It operates through three segments: Solar Power Project Development, EPC Services, and Electricity Generation Revenue. The company also develops community solar gardens; and sells projects rights. In addition, its engineering, and procurement and construction business include engineering design, procurement of solar modules, balance-of-system components and other components, and construction contracting and management services. Further, the company generates and sells electricity. As of December 31, 2020, it operated approximately 100 solar power projects with an aggregate capacity of 173 megawatts. The company has a strategic partnership agreement with Emeren Limited to co-develop ground-mounted solar projects in Italy.
Steps to owning and managing Valkyrie Bitcoin Strategy ETF units.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.